|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/0095 | (2013.01) |
| A61K 9/127 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/127 | (2013.01) | ||
| A61K 31/685 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/683 | (2013.01) | ||
| A61K 31/683 | (2006.01) | ||
| A61K 31/685 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/445 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/02 | (2018.01) | ||
| A61K 31/12 | (2006.01) | ||
| A61P 9/04 | (2018.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61P 9/06 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 9/02 | (2006.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 9/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/08 | (2006.01) |
| (11) | Number of the document | 3697386 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18868801.4 |
| Date of filing the European patent application | 2018-10-19 | |
| (97) | Date of publication of the European application | 2020-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/056721 |
| Date | 2018-10-19 |
| (87) | Number | WO 2019/079726 |
| Date | 2019-04-25 |
| (30) | Number | Date | Country code |
| 201715788683 | 2017-10-19 | US |
| (72) |
HELSON, Lawrence , US
SHOPP, George, M. , US
BOUCHARD, Annie , CA
MAJEED, Muhammed , US
|
| (73) |
Signpath Pharma, Inc. ,
9710 Ruskin Circle, Sandy, UT 84092,
US
|
| (54) | LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS |
| LIQUID COMPOSITIONS FOR PERORAL USE COMPRISING PHOSPHATIDYLGLYCEROL DERIVATIVES AND THIXOTROPIC EXCIPIENTS FOR TREATING CARDIAC CHANNELOPATHIES CAUSED BY PHARMACOLOGICAL AGENTS |